Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A

NCT02027779 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

BIOLOGICAL: GreenGene™ F
BIOLOGICAL: GreenGene™ F

Sponsor

Green Cross Corporation

Collaborators

[object Object]